It is known that cytokines like IL-12, IL-15 and IL-18 downregulate the TGF-β receptor and its signaling pathway which may contribute to the enhanced anti-tumor responses by the CIML NK cells (Fig. 2) [62]. The gene discussed is IL15; the disease is neoplasm.